Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.
about
Revealing the Complexity of Breast Cancer by Next Generation SequencingOncogenomic portals for the visualization and analysis of genome-wide cancer dataHigh Expression of Rab-like 3 (Rabl3) is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8/9/10-Mediated AutophagyTRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.The association between MMP-12 82 A/G polymorphism and susceptibility to various malignant tumors: a meta-analysisAssociation between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients.Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1.The necessity for in vivo functional analysis in human medical genetics.Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.Mutation of cancer driver MLL2 results in transcription stress and genome instability.Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Rapamycin inhibited the function of lung CSCs via SOX2.Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer.Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
P2860
Q26777395-8EEB02C9-91D2-48C2-B9DF-8F17D93088A2Q26781295-ADC94D22-2727-4D46-8576-7CB43FFD9EDBQ28829201-E15D4930-DAFA-4415-AF08-24532FD16B5FQ35854054-2175A597-E634-4087-B7B3-BA5E4A2164F8Q35896475-F91264A5-4A87-4EE2-AC0A-4E5FBB5B978BQ35918956-C704E27E-6CB7-4F80-8B9C-2E5208CDE08EQ36046292-A6847942-7598-4FA6-83E4-25DB3EDBAB99Q36046534-4580436B-6633-40C4-9F45-AD0B144CFABFQ36095147-CE2FAD6F-BA29-475E-AEB3-5DB902B951B1Q36683908-03B64B2A-5821-490C-B891-066DA96437D8Q37190448-D1C1C450-BDD5-420F-A4CC-8B8EAF81EC68Q38586777-D9B23EEF-57E9-4EA2-BAD9-FB8D7BF379B8Q38646960-86C98666-EBDA-4BC0-9534-898E81297A83Q38822762-7872054D-20E1-4EC1-BB61-180CFE247F54Q45907759-006481D2-90F8-4F81-AE07-10900655306DQ59136533-6A6C51F4-FBBF-4AB2-860E-6165211270FF
P2860
Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@en
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@nl
type
label
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@en
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@nl
prefLabel
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@en
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Exome sequencing identifies fr ...... rcinoma from Chinese patients.
@en
P2093
Chung-I Wu
Guoping Zhao
Landian Hu
Shanye Yin
Wenjun Deng
Xiangyin Kong
P2860
P2888
P356
10.1038/SREP06036
P407
P577
2014-08-12T00:00:00Z
P5875
P6179
1036868305